Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Board/Management Information 2021

Jan 6, 2021

6990_rns_2021-01-06_9bff8879-b158-4f59-bf53-81e185c79230.htm

Board/Management Information

Open in viewer

Opens in your device viewer

PSTI__8K__Board_Appointments_January_2021_ false

�������� ��������� ���� 2 380
PLURISTEM THERAPEUTICS INC
Corporation no: C12337-2001 8543
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 06/01/2021
www.isa.gov.il www.tase.co.il Reference: 2021-02-002475 Time of broadcast: 14:28 14:28

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onPSTI__8K__Board_Appointments_January_2021_

PSTI__8K__Board_Appointments_January_2021_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM Date of revision of form structure: 31/12/2020
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: [email protected]   Company site: www.pluristem.com
Previous names of reporting entity:
Name of the Signatory: Yanay Yaacov Position of Signatory in the reporting corporation: Chief Executive Officer, Director Name of Employer Company:
Address: Matam Park 5 , Haifa 31905 Telephone: 074-7107171 Facsimile: 074-7108673 E-mail: [email protected] 1